These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 1967132)

  • 21. Efficacy of daptomycin in the treatment of experimental endocarditis due to susceptible and multidrug-resistant enterococci.
    Vouillamoz J; Moreillon P; Giddey M; Entenza JM
    J Antimicrob Chemother; 2006 Dec; 58(6):1208-14. PubMed ID: 17030515
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Activity of daptomycin against staphylococci collected from bloodstream infections in Spanish medical centers.
    Picazo JJ; Betriu C; Culebras E; Rodríguez-Avial I; Gómez M; López F;
    Diagn Microbiol Infect Dis; 2009 Aug; 64(4):448-51. PubMed ID: 19631100
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Beta-Lactam-beta-lactamase-inhibitor combinations are active in experimental endocarditis caused by beta-lactamase-producing oxacillin-resistant staphylococci.
    Hirano L; Bayer AS
    Antimicrob Agents Chemother; 1991 Apr; 35(4):685-90. PubMed ID: 2069374
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Treatment of experimental chronic osteomyelitis due to Staphylococcus aureus with ampicillin/sulbactam.
    Norden CW; Budinsky A
    J Infect Dis; 1990 Jan; 161(1):52-3. PubMed ID: 2295859
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Antibacterial activity of cefoperazone and cefoperazone plus sulbactam in a neutropenic site model.
    Fasching CE; Moody JA; Sinn LM; Tenquist J; Gerding DN; Peterson LR
    Diagn Microbiol Infect Dis; 1991; 14(2):147-55. PubMed ID: 1873973
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Evaluation of high-dose daptomycin for therapy of experimental Staphylococcus aureus foreign body infection.
    Schaad HJ; Bento M; Lew DP; Vaudaux P
    BMC Infect Dis; 2006 Apr; 6():74. PubMed ID: 16608512
    [TBL] [Abstract][Full Text] [Related]  

  • 27. In vitro activities of ampicillin-sulbactam and cefoperazone-sulbactam against oxacillin-susceptible and oxacillin-resistant staphylococci.
    Barry AL; Jones RN
    Antimicrob Agents Chemother; 1990 Sep; 34(9):1830-2. PubMed ID: 2285302
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Use of cefoperazone/sulbactam in neonates.
    Ovali F; Gursoy T; Sari I; Divrikli D; Aktas A
    Pediatr Int; 2012 Feb; 54(1):60-3. PubMed ID: 21883691
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Imipenem or cefoperazone-sulbactam combined with vancomycin for therapy of presumed or proven infection in neutropenic cancer patients.
    Bodey G; Abi-Said D; Rolston K; Raad I; Whimbey E
    Eur J Clin Microbiol Infect Dis; 1996 Aug; 15(8):625-34. PubMed ID: 8894569
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cefoperazone treatment of experimental endocarditis.
    Snepar RA; Carrizosa J; Kobasa WD; Kaye D
    Antimicrob Agents Chemother; 1981 May; 19(5):773-6. PubMed ID: 6457556
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparative therapeutic efficacy of teicoplanin and vancomycin in normal and in neutropenic mice infected with Staphylococcus haemolyticus.
    Torney HL; Balistreri FJ; Kenny MT; Cheng WD
    J Antimicrob Chemother; 1991 Aug; 28(2):261-9. PubMed ID: 1838105
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Therapy of staphylococcal infections with cefamandole or vancomycin alone or with a combination of cefamandole and tobramycin.
    Coppens L; Hanson B; Klastersky J
    Antimicrob Agents Chemother; 1983 Jan; 23(1):36-41. PubMed ID: 6550482
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Randomized comparative trial with ampicillin/sulbactam versus cefamandole in the therapy of community acquired pneumonia.
    Williams D; Perri M; Zervos MJ
    Eur J Clin Microbiol Infect Dis; 1994 Apr; 13(4):293-8. PubMed ID: 8070432
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparative evaluation of cefamandole and cephalothin in the treatment of experimental Staphylococcus aureus osteomyelitis in rabbits.
    Mader JT; Wilson KJ
    J Bone Joint Surg Am; 1983 Apr; 65(4):507-13. PubMed ID: 6833327
    [No Abstract]   [Full Text] [Related]  

  • 35. Cost-effectiveness study comparing cefoperazone-sulbactam to a three-drug combination for treating intraabdominal infections in an Indian health-care setting.
    Kochhar P; Suvarna V; Duttagupta S; Sarkar S
    Value Health; 2008 Mar; 11 Suppl 1():S33-8. PubMed ID: 18387065
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Antistaphylococcal activities of teicoplanin and vancomycin in vitro and in an experimental infection.
    Peetermans WE; Hoogeterp JJ; Hazekamp-van Dokkum AM; van den Broek P; Mattie H
    Antimicrob Agents Chemother; 1990 Oct; 34(10):1869-74. PubMed ID: 2149812
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Three-year experience with the use of cefoperazone/sulbactam (sulperazone) in the treatment of hospital-acquired infections in an oncologic hospital].
    Antibiot Khimioter; 2006; 51(1):14-7. PubMed ID: 16734360
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Daptomycin versus vancomycin treatment for Staphylococcus aureus bacteremia in a murine model.
    Smith K; Cobbs G; Dill R; Lyon D; Graves A; Avent K
    Chemotherapy; 1990; 36(6):428-34. PubMed ID: 1963395
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparative penetration of six antibiotics into the cerebrospinal fluid of rabbits with experimental staphylococcal meningitis.
    Strausbaugh LJ; Murray TW; Sande MA
    J Antimicrob Chemother; 1980 May; 6(3):363-71. PubMed ID: 7400069
    [No Abstract]   [Full Text] [Related]  

  • 40. Comparative therapeutic efficacy of teicoplanin and vancomycin in normal and in neutropenic mice infected with Staphylococcus haemolyticus.
    Cunningham R
    J Antimicrob Chemother; 1992 Apr; 29(4):459-6. PubMed ID: 1535069
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.